10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001558370-24-012259 |
| Period End Date | 20240630 |
| Filing Date | 20240814 |
| Fiscal Year | 2024 |
| Fiscal Period | Q2 |
| XBRL Instance | bpth-20240630x10q_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
118 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Preferred Stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred Stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred Stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred Stock, par value |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred Stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred Stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred Stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred Stock, shares authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Cash |
Cash
|
$1.05M | USD | Point-in-time |
| Cash |
Cash
|
$1.05M | USD | Point-in-time |
| Cash |
Cash
|
$4.01M | USD | Point-in-time |
| Cash |
Cash
|
$4.01M | USD | Point-in-time |
| Preferred Stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred Stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred Stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred Stock, shares issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Prepaid drug product |
PrepaidExpenseCurrent
|
$632.00K | USD | Point-in-time |
| Prepaid drug product |
PrepaidExpenseCurrent
|
$632.00K | USD | Point-in-time |
| Preferred Stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred Stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred Stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred Stock, shares outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Prepaid drug product |
PrepaidExpenseCurrent
|
$274.00K | USD | Point-in-time |
| Prepaid drug product |
PrepaidExpenseCurrent
|
$274.00K | USD | Point-in-time |
| Common Stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common Stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common Stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common Stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$1.36M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$1.36M | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$739.00K | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$739.00K | USD | Point-in-time |
| Common Stock, shares authorized |
CommonStockSharesAuthorized
|
200.00M | shares | Point-in-time |
| Common Stock, shares authorized |
CommonStockSharesAuthorized
|
200.00M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$3.04M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$3.04M | USD | Point-in-time |
| Common Stock, shares authorized |
CommonStockSharesAuthorized
|
200.00M | shares | Point-in-time |
| Common Stock, shares authorized |
CommonStockSharesAuthorized
|
200.00M | shares | Point-in-time |
| Total current assets |
AssetsCurrent
|
$5.02M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$5.02M | USD | Point-in-time |
| Common Stock, shares issued |
CommonStockSharesIssued
|
2.28M | shares | Point-in-time |
| Common Stock, shares issued |
CommonStockSharesIssued
|
2.28M | shares | Point-in-time |
| Common Stock, shares issued |
CommonStockSharesIssued
|
618,000.00 | shares | Point-in-time |
| Common Stock, shares issued |
CommonStockSharesIssued
|
618,000.00 | shares | Point-in-time |
| Furniture, fixtures & equipment |
PropertyPlantAndEquipmentGross
|
$1.12M | USD | Point-in-time |
| Furniture, fixtures & equipment |
PropertyPlantAndEquipmentGross
|
$1.12M | USD | Point-in-time |
| Common Stock, shares outstanding |
CommonStockSharesOutstanding
|
618,000.00 | shares | Point-in-time |
| Common Stock, shares outstanding |
CommonStockSharesOutstanding
|
618,000.00 | shares | Point-in-time |
| Common Stock, shares outstanding |
CommonStockSharesOutstanding
|
2.28M | shares | Point-in-time |
| Common Stock, shares outstanding |
CommonStockSharesOutstanding
|
2.28M | shares | Point-in-time |
| Furniture, fixtures & equipment |
PropertyPlantAndEquipmentGross
|
$1.12M | USD | Point-in-time |
| Furniture, fixtures & equipment |
PropertyPlantAndEquipmentGross
|
$1.12M | USD | Point-in-time |
| Less accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.07M | USD | Point-in-time |
| Less accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.07M | USD | Point-in-time |
| Less accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.04M | USD | Point-in-time |
| Less accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$1.04M | USD | Point-in-time |
| Fixed assets, net |
PropertyPlantAndEquipmentNet
|
$76.00K | USD | Point-in-time |
| Fixed assets, net |
PropertyPlantAndEquipmentNet
|
$76.00K | USD | Point-in-time |
| Fixed assets, net |
PropertyPlantAndEquipmentNet
|
$48.00K | USD | Point-in-time |
| Fixed assets, net |
PropertyPlantAndEquipmentNet
|
$48.00K | USD | Point-in-time |
| Right of use operating assets |
OperatingLeaseRightOfUseAsset
|
$51.00K | USD | Point-in-time |
| Right of use operating assets |
OperatingLeaseRightOfUseAsset
|
$51.00K | USD | Point-in-time |
| Right of use operating assets |
OperatingLeaseRightOfUseAsset
|
$102.00K | USD | Point-in-time |
| Right of use operating assets |
OperatingLeaseRightOfUseAsset
|
$102.00K | USD | Point-in-time |
| Total Assets |
Assets
|
$5.12M | USD | Point-in-time |
| Total Assets |
Assets
|
$5.12M | USD | Point-in-time |
| Total Assets |
Assets
|
$3.22M | USD | Point-in-time |
| Total Assets |
Assets
|
$3.22M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$457.00K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$457.00K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$766.00K | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$766.00K | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$2.19M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$2.19M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.35M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.35M | USD | Point-in-time |
| Current portion of lease liabilities |
OperatingLeaseLiabilityCurrent
|
$103.00K | USD | Point-in-time |
| Current portion of lease liabilities |
OperatingLeaseLiabilityCurrent
|
$103.00K | USD | Point-in-time |
| Current portion of lease liabilities |
OperatingLeaseLiabilityCurrent
|
$55.00K | USD | Point-in-time |
| Current portion of lease liabilities |
OperatingLeaseLiabilityCurrent
|
$55.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.91M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$1.91M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$3.01M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$3.01M | USD | Point-in-time |
| Warrant liability |
WarrantsAndRightsOutstanding
|
$817.00K | USD | Point-in-time |
| Warrant liability |
WarrantsAndRightsOutstanding
|
$817.00K | USD | Point-in-time |
| Warrant liability |
WarrantsAndRightsOutstanding
|
$863.00K | USD | Point-in-time |
| Warrant liability |
WarrantsAndRightsOutstanding
|
$863.00K | USD | Point-in-time |
| Noncurrent lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$10.00K | USD | Point-in-time |
| Noncurrent lease liabilities |
OperatingLeaseLiabilityNoncurrent
|
$10.00K | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$3.83M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$3.83M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$2.78M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$2.78M | USD | Point-in-time |
| Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $.001 par value; 200,000 shares authorized; 2,283 and 618 shares issued and outstanding, respectively |
CommonStockValue
|
$1.00K | USD | Point-in-time |
| Common stock, $.001 par value; 200,000 shares authorized; 2,283 and 618 shares issued and outstanding, respectively |
CommonStockValue
|
$1.00K | USD | Point-in-time |
| Common stock, $.001 par value; 200,000 shares authorized; 2,283 and 618 shares issued and outstanding, respectively |
CommonStockValue
|
$2.00K | USD | Point-in-time |
| Common stock, $.001 par value; 200,000 shares authorized; 2,283 and 618 shares issued and outstanding, respectively |
CommonStockValue
|
$2.00K | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapital
|
$108.05M | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapital
|
$108.05M | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapital
|
$113.92M | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapital
|
$113.92M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-112.63M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-112.63M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-107.61M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-107.61M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$441.00K | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$441.00K | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$1.29M | USD | Point-in-time |
| Total shareholders' equity |
StockholdersEquity
|
$1.29M | USD | Point-in-time |
| Total Liabilities & Shareholders' Equity |
LiabilitiesAndStockholdersEquity
|
$5.12M | USD | Point-in-time |
| Total Liabilities & Shareholders' Equity |
LiabilitiesAndStockholdersEquity
|
$5.12M | USD | Point-in-time |
| Total Liabilities & Shareholders' Equity |
LiabilitiesAndStockholdersEquity
|
$3.22M | USD | Point-in-time |
| Total Liabilities & Shareholders' Equity |
LiabilitiesAndStockholdersEquity
|
$3.22M | USD | Point-in-time |
Income Statement
92 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Research and development |
ResearchAndDevelopmentExpense
|
$1.87M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$1.87M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$7.04M | USD | 2 Qtrs |
| Research and development |
ResearchAndDevelopmentExpense
|
$7.04M | USD | 2 Qtrs |
| Research and development |
ResearchAndDevelopmentExpense
|
$3.05M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$3.05M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$4.16M | USD | 2 Qtrs |
| Research and development |
ResearchAndDevelopmentExpense
|
$4.16M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$2.49M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$2.49M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.19M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.19M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$2.57M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$2.57M | USD | 2 Qtrs |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.17M | USD | 1 Quarter |
| General and administrative |
GeneralAndAdministrativeExpense
|
$1.17M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$9.53M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$9.53M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$6.73M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$6.73M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$4.24M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$4.24M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$3.04M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$3.04M | USD | 1 Quarter |
| Net operating loss |
OperatingIncomeLoss
|
$-9.53M | USD | 2 Qtrs |
| Net operating loss |
OperatingIncomeLoss
|
$-9.53M | USD | 2 Qtrs |
| Net operating loss |
OperatingIncomeLoss
|
$-6.73M | USD | 2 Qtrs |
| Net operating loss |
OperatingIncomeLoss
|
$-6.73M | USD | 2 Qtrs |
| Net operating loss |
OperatingIncomeLoss
|
$-3.04M | USD | 1 Quarter |
| Net operating loss |
OperatingIncomeLoss
|
$-3.04M | USD | 1 Quarter |
| Net operating loss |
OperatingIncomeLoss
|
$-4.24M | USD | 1 Quarter |
| Net operating loss |
OperatingIncomeLoss
|
$-4.24M | USD | 1 Quarter |
| Change in fair value of warrant liability |
PeriodChangesInFairValueOfWarrantLiability
|
$-1.16M | USD | 1 Quarter |
| Change in fair value of warrant liability |
PeriodChangesInFairValueOfWarrantLiability
|
$-1.16M | USD | 1 Quarter |
| Change in fair value of warrant liability |
PeriodChangesInFairValueOfWarrantLiability
|
$-1.70M | USD | 2 Qtrs |
| Change in fair value of warrant liability |
PeriodChangesInFairValueOfWarrantLiability
|
$-1.70M | USD | 2 Qtrs |
| Interest income |
InvestmentIncomeInterest
|
$6.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$6.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$6.00K | USD | 2 Qtrs |
| Interest income |
InvestmentIncomeInterest
|
$6.00K | USD | 2 Qtrs |
| Interest income |
InvestmentIncomeInterest
|
$8.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$8.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$27.00K | USD | 2 Qtrs |
| Interest income |
InvestmentIncomeInterest
|
$27.00K | USD | 2 Qtrs |
| Total other income |
NonoperatingIncomeExpense
|
$8.00K | USD | 1 Quarter |
| Total other income |
NonoperatingIncomeExpense
|
$8.00K | USD | 1 Quarter |
| Total other income |
NonoperatingIncomeExpense
|
$27.00K | USD | 2 Qtrs |
| Total other income |
NonoperatingIncomeExpense
|
$27.00K | USD | 2 Qtrs |
| Total other income |
NonoperatingIncomeExpense
|
$1.17M | USD | 1 Quarter |
| Total other income |
NonoperatingIncomeExpense
|
$1.17M | USD | 1 Quarter |
| Total other income |
NonoperatingIncomeExpense
|
$1.71M | USD | 2 Qtrs |
| Total other income |
NonoperatingIncomeExpense
|
$1.71M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-4.23M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-4.23M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-1.87M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-1.87M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-9.51M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-9.51M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-5.03M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-5.03M | USD | 2 Qtrs |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-23.89 | USD | 2 Qtrs |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-23.89 | USD | 2 Qtrs |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-1.16 | USD | 1 Quarter |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-1.16 | USD | 1 Quarter |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-10.64 | USD | 1 Quarter |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-10.64 | USD | 1 Quarter |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-4.45 | USD | 2 Qtrs |
| Net loss per share, basic |
EarningsPerShareBasic
|
$-4.45 | USD | 2 Qtrs |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
398,000.00 | shares | 1 Quarter |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
398,000.00 | shares | 1 Quarter |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.13M | shares | 2 Qtrs |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.13M | shares | 2 Qtrs |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.61M | shares | 1 Quarter |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
1.61M | shares | 1 Quarter |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
398,000.00 | shares | 2 Qtrs |
| Weighted average number of common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
398,000.00 | shares | 2 Qtrs |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-1.16 | USD | 1 Quarter |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-1.16 | USD | 1 Quarter |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-4.45 | USD | 2 Qtrs |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-4.45 | USD | 2 Qtrs |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-10.64 | USD | 1 Quarter |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-10.64 | USD | 1 Quarter |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-23.89 | USD | 2 Qtrs |
| Net loss per share, diluted |
EarningsPerShareDiluted
|
$-23.89 | USD | 2 Qtrs |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
398,000.00 | shares | 1 Quarter |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
398,000.00 | shares | 1 Quarter |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.13M | shares | 2 Qtrs |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.13M | shares | 2 Qtrs |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.61M | shares | 1 Quarter |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
1.61M | shares | 1 Quarter |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
398,000.00 | shares | 2 Qtrs |
| Weighted average number of common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
398,000.00 | shares | 2 Qtrs |
Cash Flow Statement
62 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-9.51M | USD | 2 Qtrs |
| Net loss |
ProfitLoss
|
$-9.51M | USD | 2 Qtrs |
| Net loss |
ProfitLoss
|
$-5.03M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-5.03M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$376.00K | USD | 2 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$376.00K | USD | 2 Qtrs |
| Stock-based compensation |
ShareBasedCompensation
|
$311.00K | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$311.00K | USD | 1 Quarter |
| Amortization of right of use assets |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$47.00K | USD | 2 Qtrs |
| Amortization of right of use assets |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$47.00K | USD | 2 Qtrs |
| Amortization of right of use assets |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$51.00K | USD | 1 Quarter |
| Amortization of right of use assets |
OperatingLeaseRightOfUseAssetAmortizationExpense
|
$51.00K | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$28.00K | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$28.00K | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$44.00K | USD | 2 Qtrs |
| Depreciation |
Depreciation
|
$44.00K | USD | 2 Qtrs |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-1.70M | USD | 1 Quarter |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-1.70M | USD | 1 Quarter |
| Prepaid drug product |
IncreaseDecreaseInPrepaidExpense
|
$-2.52M | USD | 2 Qtrs |
| Prepaid drug product |
IncreaseDecreaseInPrepaidExpense
|
$-2.52M | USD | 2 Qtrs |
| Prepaid drug product |
IncreaseDecreaseInPrepaidExpense
|
$-358.00K | USD | 1 Quarter |
| Prepaid drug product |
IncreaseDecreaseInPrepaidExpense
|
$-358.00K | USD | 1 Quarter |
| Other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$-619.00K | USD | 1 Quarter |
| Other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$-619.00K | USD | 1 Quarter |
| Other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$102.00K | USD | 2 Qtrs |
| Other current assets |
IncreaseDecreaseInOtherCurrentAssets
|
$102.00K | USD | 2 Qtrs |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$1.15M | USD | 1 Quarter |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$1.15M | USD | 1 Quarter |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-263.00K | USD | 2 Qtrs |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-263.00K | USD | 2 Qtrs |
| Lease liabilities |
IncreaseDecreaseInOperatingLeaseLiability
|
$-53.00K | USD | 2 Qtrs |
| Lease liabilities |
IncreaseDecreaseInOperatingLeaseLiability
|
$-53.00K | USD | 2 Qtrs |
| Lease liabilities |
IncreaseDecreaseInOperatingLeaseLiability
|
$-58.00K | USD | 1 Quarter |
| Lease liabilities |
IncreaseDecreaseInOperatingLeaseLiability
|
$-58.00K | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-4.27M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-4.27M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-6.94M | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-6.94M | USD | 2 Qtrs |
| Net proceeds from sale of common stock |
ProceedsFromIssuanceOfCommonStock
|
$7.22M | USD | 1 Quarter |
| Net proceeds from sale of common stock |
ProceedsFromIssuanceOfCommonStock
|
$7.22M | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$7.22M | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$7.22M | USD | 1 Quarter |
| Net decrease in cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-6.94M | USD | 2 Qtrs |
| Net decrease in cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-6.94M | USD | 2 Qtrs |
| Net decrease in cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$2.95M | USD | 1 Quarter |
| Net decrease in cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$2.95M | USD | 1 Quarter |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.05M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.05M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.38M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.38M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.44M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.44M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.01M | USD | Point-in-time |
| Cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.01M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.05M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.05M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.38M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$10.38M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.44M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$3.44M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.01M | USD | Point-in-time |
| Cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$4.01M | USD | Point-in-time |
Stockholders Equity
44 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-2.62M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-2.62M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.17M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.17M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.11M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.11M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.04M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.04M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$441.00K | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$441.00K | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.29M | USD | Point-in-time |
| Stockholders' equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.29M | USD | Point-in-time |
| Issuance of common stock and warrants, net of fees and warrant liability |
StockIssuedDuringPeriodValueNewIssues
|
$5.57M | USD | 2 Qtrs |
| Issuance of common stock and warrants, net of fees and warrant liability |
StockIssuedDuringPeriodValueNewIssues
|
$5.57M | USD | 2 Qtrs |
| Issuance of common stock and warrants, net of fees and warrant liability |
StockIssuedDuringPeriodValueNewIssues
|
$5.64M | USD | 1 Quarter |
| Issuance of common stock and warrants, net of fees and warrant liability |
StockIssuedDuringPeriodValueNewIssues
|
$5.64M | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$141.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$141.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$170.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$170.00K | USD | 1 Quarter |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$376.00K | USD | 2 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$376.00K | USD | 2 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$311.00K | USD | 2 Qtrs |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$311.00K | USD | 2 Qtrs |
| Net Income (Loss) |
NetIncomeLoss
|
$-4.23M | USD | 1 Quarter |
| Net Income (Loss) |
NetIncomeLoss
|
$-4.23M | USD | 1 Quarter |
| Net Income (Loss) |
NetIncomeLoss
|
$-1.87M | USD | 1 Quarter |
| Net Income (Loss) |
NetIncomeLoss
|
$-1.87M | USD | 1 Quarter |
| Net Income (Loss) |
NetIncomeLoss
|
$-9.51M | USD | 2 Qtrs |
| Net Income (Loss) |
NetIncomeLoss
|
$-9.51M | USD | 2 Qtrs |
| Net Income (Loss) |
NetIncomeLoss
|
$-5.03M | USD | 2 Qtrs |
| Net Income (Loss) |
NetIncomeLoss
|
$-5.03M | USD | 2 Qtrs |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-2.62M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$-2.62M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.17M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$14.17M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.11M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.11M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.04M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$5.04M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$441.00K | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$441.00K | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.29M | USD | Point-in-time |
| Stockholders' equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$1.29M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.